RASGRP2 Suppresses Apoptosis via Inhibition of ROS Production in Vascular Endothelial Cells by Takuma Sato, Jun-ichi Takino, Kentaro Nagamine, Kazuto Nishio, Takamitsu Hori

Get full text

Comparison of genetic mutations in bladder cancers that arose following radiotherapy for prostate cancer with those in primary bladder cancers by Shogo Adomi, Kazuko Sakai, Yurie Kura, Marco A De Velasco, Saizo Fujimoto, Shingo Toyoda, Mamoru Hashimoto, Mitsuhisa Nishimoto, Eri Banno, Yoshitaka Saito, Koichi Sugimoto, Yujiro Hayashi, Takafumi Minami, Kazuhiro Yoshimura, Hirotsugu Uemura, Kazuto Nishio, Kazutoshi Fujita

Get full text

Slug increases sensitivity to tubulin‐binding agents via the downregulation of βIII and βIVa‐tubulin in lung cancer cells by Daisuke Tamura, Tokuzo Arao, Tomoyuki Nagai, Hiroyasu Kaneda, Keiichi Aomatsu, Yoshihiko Fujita, Kazuko Matsumoto, Marco A. DeVelasco, Hiroaki Kato, Hidetoshi Hayashi, Shuhei Yoshida, Hideharu Kimura, Yoshimasa Maniwa, Wataru Nishio, Yasuhiro Sakai, Chiho Ohbayashi, Yoshikazu Kotani, Yoshihiro Nishimura, Kazuto Nishio

Get full text

Chromosomal Instability Is Associated with cGAS–STING Activation in EGFR-TKI Refractory Non-Small-Cell Lung Cancer by Kimio Yonesaka, Takashi Kurosaki, Junko Tanizaki, Hisato Kawakami, Kaoru Tanaka, Osamu Maenishi, Shiki Takamura, Kazuko Sakai, Yasutaka Chiba, Takeshi Teramura, Hiroki Goto, Eri Otsuka, Hiroaki Okida, Masanori Funabashi, Yuuri Hashimoto, Kenji Hirotani, Yasuki Kamai, Takashi Kagari, Kazuto Nishio, Kazuhiro Kakimi, Hidetoshi Hayashi

Get full text

Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway by Tomoko Aoki, Naoshi Nishida, Yutaka Kurebayashi, Kazuko Sakai, Naoto Fujiwara, Masakatsu Tsurusaki, Kohei Hanaoka, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Hiroshi Ida, Kazuomi Ueshima, Yasunori Minami, Atsushi Takebe, Takaaki Murase, Keiko Kamei, Takuya Nakai, Ippei Matsumoto, Kazuto Nishio, Masatoshi Kudo

Get full text

Final Survival Outcomes With Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated EGFR-Mutated Metastatic NSCLC: RELAY Japanese Subset by Makoto Nishio, MD, PhD, Takashi Seto, MD, PhD, Martin Reck, PhD, Edward B. Garon, MD, Kazuto Nishio, MD, PhD, Kazuo Kasahara, MD, PhD, Kazumi Nishino, MD, PhD, Miyako Satouchi, MD, PhD, Kiyotaka Yoh, MD, Hidetoshi Hayashi, MD, PhD, Kazuko Sakai, PhD, Sotaro Enatsu, MD, PhD, Bente Frimodt-Møller, MSc, Tomoko Matsui, Sunoj Chacko Varughese, MSc, Michelle Carlsen, MS, Carla Visseren-Grul, MD, Kazuhiko Nakagawa, MD, PhD

Get full text